Learn how a large, multi-site study supports laboratory adoption of extragenital CT/NG testing on an automated, high throughput platform. This episode reviews importance of extragenital sample collection for STI testing, performance of extragenital STI testing on the BD COR™ System, and operational benefits of high-throughput automation.
Disclaimer: Waters Corporation has acquired BD [Biosciences/Diagnostic Solutions]. BD remains the legal manufacturer until all required regulatory transfers are complete. Learn more: www.waters.com/bdtransaction
Fler avsnitt av Inside Molecular: Conversations Across BD Molecular Diagnostics
Visa alla avsnitt av Inside Molecular: Conversations Across BD Molecular DiagnosticsInside Molecular: Conversations Across BD Molecular Diagnostics med BD Molecular Diagnostics finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
